In the face of rising health care costs, payers are today exerting a much greater influence over the pharmaceutical market re becoming increasingly demanding of pharmaceutical companies to provide greater insight into a drug’s cost effectiveness compared with alternative drugs and generics. To succeed in the market, Evolve Selection recognise that pharmaceutical companies must revamp the way that they market drugs; making Market Access planning an integral part of commercialisation strategies.
Evolve Selection Market Access division www.evolveselection.co.uk offer a bespoke consultancy service to design, implement and project manage bespoke market access solutions. Whilst acknowledging the importance of payers and how they differ, many companies have developed regional account sales teams to cultivate closer ties with payers. Others have launched efforts aimed at collecting more data on payers and their decision-making processes. Some companies have experimented with performance-based contract provisions to better align their goals with payers. These efforts may have incremental benefits, but they may be insufficient given the scope of the Market Access challenges confronting pharmaceutical companies today.
Evolve Selection Market Access work in partnership with clients to help design and shape organisational changes to meet new Market Access challenges. Combined with our in-house recruitment and contract sales divisions, Evolve Selection offer a full end to end consultancy service designed to aid clients through the necessary change.
Evolve Selection are a pioneering company in sales recruitment, offering pharmaceutical jobs, pharmaceutical sales careers, pharmaceutical recruitment and pharmaceutical sales jobs.
For further information contact:-
4 Appleton Court
Telephone: 0844 357 7332
Email: chris ( @ ) evolveselection dot co.uk